Drug development, often hampered by siloed clinical data, just got a boost from Century Health, which has raised $5.0M in seed funding. The startup applies artificial intelligence to real-world data, aiming to accelerate the path from research to commercialization.
Century Health's platform is designed to rapidly extract critical insights from complex, locked-away clinical information. This approach seeks to overcome the current slowness in answering vital questions, all while maintaining patient privacy and supporting the broader research community.













